Filter by: patients
Home > Community Treatment Reports and Side Effects > Amisulpride Treatment Report
What is Amisulpride?

Amisulpride (brand-name Solian) is an antipsychotic drug sold by Sanofi-Aventis. Amisulpride is not approved by the Food and Drug Administration for use in the United States, but it is used in Europe and Australia to treat psychoses and schizophrenia.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Bipolar Disorder 2 1 Efficacy_none
Other 1 0
Depressed mood 1 1 Efficacy_slight
Schizophrenia 1 0
PTSD (Post Traumatic Stress Disorder) 1 0
Borderline Personality Disorder 1 0

See all 8 patients currently taking Amisulpride

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Amisulpride

Excessive daytime sleepiness (somnolence) 1
Emotional numbness or flatness 1
Diabetes Type 2 1
Obesity 1

Reported Dosages

  daily 50 mg daily 100 mg daily 200 mg daily 300 mg daily 350 mg daily 400 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Amisulpride (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 67%
Doctor's advice 2   Doctor's advice: 67%
Side effects too severe 1   Side effects too severe: 33%
Other 1   Other: 33%
Course of treatment ended 1   Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Amisulpride

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Amisulpride

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Amisulpride

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Amisulpride

Always
 2 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Amisulpride

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 2 100%

Cost

Paid out of pocket

Cost of Amisulpride

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 50%
$25-49
 0 0%
< $25
 1 50%

Report created on May 28, 2012.